Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Accumulated Expenses (2023 - 2025)

Historic Accumulated Expenses for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $4.1 million.

  • Camp4 Therapeutics' Accumulated Expenses rose 1055.21% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 1055.21%. This contributed to the annual value of $4.8 million for FY2024, which is 4636.58% up from last year.
  • Latest data reveals that Camp4 Therapeutics reported Accumulated Expenses of $4.1 million as of Q3 2025, which was up 1055.21% from $2.9 million recorded in Q2 2025.
  • Camp4 Therapeutics' Accumulated Expenses' 5-year high stood at $4.8 million during Q4 2024, with a 5-year trough of $1.8 million in Q1 2025.
  • Moreover, its 3-year median value for Accumulated Expenses was $3.5 million (2023), whereas its average is $3.4 million.
  • Per our database at Business Quant, Camp4 Therapeutics' Accumulated Expenses soared by 4636.58% in 2024 and then skyrocketed by 1055.21% in 2025.
  • Quarter analysis of 3 years shows Camp4 Therapeutics' Accumulated Expenses stood at $3.3 million in 2023, then surged by 46.37% to $4.8 million in 2024, then dropped by 15.89% to $4.1 million in 2025.
  • Its last three reported values are $4.1 million in Q3 2025, $2.9 million for Q2 2025, and $1.8 million during Q1 2025.